Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan W Jonker

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|November 9, 2014
New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug dispositionLori W E van der Schoor, Henkjan J Verkade, Folkert Kuipers, et al.
Molecular Pharmacology|February 22, 2005
Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liverGracia Merino, Antonius E van Herwaarden, Els Wagenaar, et al.
Molecular Pharmacology|February 15, 2005
The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoinGracia Merino, Johan W Jonker, Els Wagenaar, et al.
Expert Opinion on Investigational Drugs|January 5, 2020
Pegbelfermin (BMS-986036): an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitisCristy R C Verzijl, Ivo P Van De Peppel, Dicky Struik, et al.
Molecular Pharmacology|March 20, 2003
Involvement of organic cation transporter 1 in the lactic acidosis caused by metforminDe-Sheng Wang, Hiroyuki Kusuhara, Yukio Kato, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2002
Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metforminDe-Sheng Wang, Johan W Jonker, Yukio Kato, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 15, 2004
Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidinePetr Pavek, Gracia Merino, Els Wagenaar, et al.
Carcinogenesis|July 8, 2005
Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milkAntonius E van Herwaarden, Els Wagenaar, Barbara Karnekamp, et al.
Frontiers in Endocrinology|February 18, 2021
The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver DiseaseAldo Grefhorst, Ivo P van de Peppel, Lars E Larsen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 12, 2018
Bile acid homeostasis in gastrointestinal and metabolic complications of cystic fibrosisIvo P van de Peppel, Frank A J A Bodewes, Henkjan J Verkade, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Expert Opinion on Drug Metabolism & Toxicology|November 9, 2014
New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug dispositionLori W E van der Schoor, Henkjan J Verkade, Folkert Kuipers, et al.
Molecular Pharmacology|February 22, 2005
Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liverGracia Merino, Antonius E van Herwaarden, Els Wagenaar, et al.
Molecular Pharmacology|February 15, 2005
The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoinGracia Merino, Johan W Jonker, Els Wagenaar, et al.
Expert Opinion on Investigational Drugs|January 5, 2020
Pegbelfermin (BMS-986036): an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitisCristy R C Verzijl, Ivo P Van De Peppel, Dicky Struik, et al.
Molecular Pharmacology|March 20, 2003
Involvement of organic cation transporter 1 in the lactic acidosis caused by metforminDe-Sheng Wang, Hiroyuki Kusuhara, Yukio Kato, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2002
Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metforminDe-Sheng Wang, Johan W Jonker, Yukio Kato, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 15, 2004
Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidinePetr Pavek, Gracia Merino, Els Wagenaar, et al.
Carcinogenesis|July 8, 2005
Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milkAntonius E van Herwaarden, Els Wagenaar, Barbara Karnekamp, et al.
Frontiers in Endocrinology|February 18, 2021
The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver DiseaseAldo Grefhorst, Ivo P van de Peppel, Lars E Larsen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 12, 2018
Bile acid homeostasis in gastrointestinal and metabolic complications of cystic fibrosisIvo P van de Peppel, Frank A J A Bodewes, Henkjan J Verkade, et al.
Pageof 10